Skip to Content
Merck
All Photos(1)

Key Documents

V800326

Sigma-Aldrich

Potassium iodide

AR, ≥99.8%

Sign Into View Organizational & Contract Pricing


About This Item

Linear Formula:
KI
CAS Number:
Molecular Weight:
166.00
EC Number:
MDL number:
UNSPSC Code:
12352302
PubChem Substance ID:

grade

AR

vapor pressure

1 mmHg ( 745 °C)

product line

Vetec

Assay

≥99.8%

form

solid

pH

~6.9 (20 °C, 50 g/L)

mp

681 °C (lit.)

cation traces

Fe: ≤0.0002%
heavy metals (as Pb): ≤0.0005%

SMILES string

[K+].[I-]

InChI

1S/HI.K/h1H;/q;+1/p-1

InChI key

NLKNQRATVPKPDG-UHFFFAOYSA-M

Looking for similar products? Visit Product Comparison Guide

Legal Information

Vetec is a trademark of Merck KGaA, Darmstadt, Germany

Pictograms

Health hazard

Signal Word

Danger

Hazard Statements

Precautionary Statements

Hazard Classifications

STOT RE 1 Oral

Target Organs

Thyroid

Storage Class Code

6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects

WGK

WGK 3


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Pietro Santulli et al.
Human reproduction (Oxford, England), 30(1), 49-60 (2014-11-08)
Are protein oxidative stress markers [thiols, advanced oxidation protein products (AOPP), protein carbonyls and nitrates/nitrites] in perioperative peritoneal fluid higher in women with histologically proven endometriosis when compared with endometriosis-free controls? Protein oxidative stress markers are significantly increased in peritoneal
S C Clement et al.
Pediatric blood & cancer, 60(11), 1833-1838 (2013-07-09)
Thyroid dysfunction has been reported in up to 52% of patients 1.4 years after treatment with (131) I-Metaiodobenzylguanidine (MIBG) in children with neuroblastoma (NBL), despite the use of potassium-iodide (KI). Our aim was to investigate if the incidence and severity
Rahul Singh et al.
Carbohydrate polymers, 91(2), 682-685 (2012-11-06)
We report a new biopolymer electrolyte for dye sensitized solar cell application. To develop polymer electrolyte, potassium iodide have been added in agarose biopolymer matrix and characterized using various techniques like complex impedance spectroscopy, Infrared spectroscopy (IR), X-ray diffraction (XRD)
Zhi-Qi Lao et al.
Organic & biomolecular chemistry, 10(39), 7869-7871 (2012-09-06)
We have developed a new KI-catalyzed method for the imidation of an sp(3) C-H bond adjacent to an amide nitrogen atom by using TBHP (tert-butyl hydroperoxide, 70% aqueous solution) as the oxidant. This novel procedure tolerated air and moisture and
J B Sterling et al.
Journal of the American Academy of Dermatology, 43(4), 691-697 (2000-09-27)
Potassium iodide (KI) is a useful drug in the dermatologic armamentarium. It is successfully used for inflammatory dermatoses, most notably erythema nodosum, subacute nodular migratory panniculitis, nodular vasculitis, erythema multiforme, and Sweet's syndrome. KI is also successfully used for cutaneous

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service